Brokerages Set Stericycle, Inc. (NASDAQ:SRCL) Target Price at $62.25

Stericycle, Inc. (NASDAQ:SRCL) has received a consensus recommendation of “Hold” from the five research firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $59.40.

Several analysts have recently commented on SRCL shares. Truist Financial dropped their price objective on shares of Stericycle from $57.00 to $50.00 and set a “hold” rating on the stock in a report on Monday. StockNews.com cut shares of Stericycle from a “buy” rating to a “hold” rating in a research note on Tuesday, April 2nd. Stifel Nicolaus boosted their target price on shares of Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a research note on Thursday, February 29th. Royal Bank of Canada reiterated an “outperform” rating and issued a $69.00 target price on shares of Stericycle in a research note on Thursday, March 7th. Finally, Wells Fargo & Company boosted their target price on shares of Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a research note on Friday, March 1st.

Stericycle Stock Down 1.5 %

SRCL stock opened at $44.73 on Friday. The firm’s fifty day simple moving average is $51.27 and its 200-day simple moving average is $48.26. The company has a market capitalization of $4.15 billion, a P/E ratio of -203.32, a price-to-earnings-growth ratio of 2.49 and a beta of 1.09. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.11 and a quick ratio of 1.11. Stericycle has a 12 month low of $37.78 and a 12 month high of $57.06.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 EPS for the quarter, beating the consensus estimate of $0.54 by $0.03. The business had revenue of $664.90 million for the quarter, compared to the consensus estimate of $676.42 million. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The business’s revenue for the quarter was down 2.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.49 EPS. As a group, equities research analysts forecast that Stericycle will post 2.32 earnings per share for the current year.

Hedge Funds Weigh In On Stericycle

A number of large investors have recently added to or reduced their stakes in SRCL. Capital Research Global Investors raised its position in Stericycle by 13.4% during the fourth quarter. Capital Research Global Investors now owns 5,987,937 shares of the business services provider’s stock worth $296,762,000 after acquiring an additional 705,586 shares during the period. Sei Investments Co. raised its position in Stericycle by 35.5% during the fourth quarter. Sei Investments Co. now owns 1,061,369 shares of the business services provider’s stock worth $52,601,000 after acquiring an additional 277,896 shares during the period. Ariel Investments LLC raised its position in Stericycle by 5.7% during the third quarter. Ariel Investments LLC now owns 4,328,036 shares of the business services provider’s stock worth $193,506,000 after acquiring an additional 233,612 shares during the period. Heartland Advisors Inc. raised its position in Stericycle by 55.5% during the fourth quarter. Heartland Advisors Inc. now owns 583,545 shares of the business services provider’s stock worth $29,733,000 after acquiring an additional 208,256 shares during the period. Finally, Dimensional Fund Advisors LP raised its position in Stericycle by 10.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,971,719 shares of the business services provider’s stock worth $97,720,000 after acquiring an additional 192,045 shares during the period. 98.82% of the stock is currently owned by institutional investors and hedge funds.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.